FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children

Article Link: FDA Approves Lampit (nifurtimox) for the Treatment of Chagas Disease in Children

WHIPPANY, N.J.–(BUSINESS WIRE) August 7, 2020 — Bayer announced today that the United States Food and Drug Administration (FDA) has approved Lampit (nifurtimox) for use in pediatric patients (from birth to less than 18 years of age and weighing at…

Source: FDA New Drug Approvals